Related Experiment Videos
Antifungal susceptibilities of Cryptococcus neoformans
Lennox K Archibald1, Marion J Tuohy, Deborah A Wilson
1Natioanl Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Larchibald@rtix.com
Emerging Infectious Diseases
|April 14, 2004
Abstract:
Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from Thailand, Malawi, and the United States and found no evidence of resistance or MIC profile differences among the countries.